ARCHIVES

Early ADT Doesn’t Offer Survival Advantage—ASCO

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI To Stop All Support For WHT After March 31

February 5, 1988

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

Five Years after Proton Therapy, 75-99% of Men Live Cancer-Free

February 28, 2014

House Overrides Veto Of Authorization Bill As GOP Members Join Democrats In Assailing Reagan Action

November 15, 1985